TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | 13 | 23 | -5 | -33 | 0 | 0 | 
| P | %wins | 100 | 100 | 100 | 0 | 0 | 60 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/29/21 21:32  | 12/28/21  | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Schroeder Theodore R | PA | DO | CEO | P | 57 | 0.5732 | 0 | 100 | 44 | 326 | D | ||||||||||||||
9/15/21 20:00  | 9/14/21  | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Schroeder Theodore R | PA | DO | CEO | P | 57 | 1.13 | 0 | 50 | 28 | 227 | D | ||||||||||||||
8/28/19 16:01  | 8/27/19  | NBRV | Nabriva Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Schroeder Theodore R | PA | DO | CEO | P | 90 | 1.79 | 0 | 50 | 68 | 123 | I | ||||||||||||||
5/17/11 18:18  | 5/17/11  | CADX | Cadence Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Schroeder Theodore R | CA | DO | P,CEO | P | 120 | 7.48 | 4 | 16 | 5 | 308 | I | -20 | -14 | -6 | 3 | -20 | -7 | -4 | 5 | 3 | 13 | 23 | -5 | -33 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |